Ilknur Keskin

Dr. Ilknur Keskin


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2016 in Acta Histochemica
Verified
Journal Article
Closed access
TDTuran Demircan
Turan Demircan
AİAyşe Elif İlhan
Ayşe Elif İlhan
NANilüfer Aytürk
Nilüfer Aytürk
Berna YıldırımBerna Yıldırım
Berna Yıldırım
GOGurkan Ozturk
Gurkan Ozturk
IKIlknur Keskin
Ilknur Keskin

1 May 2021 in Reproductive BioMedicine Online
Verified
Journal Article
Closed access
BEBircan Kolbaşı Erkan
Bircan Kolbaşı Erkan
MBMuhammet Volkan Bulbul
Muhammet Volkan Bulbul
SKSeda Karabulut
Seda Karabulut
CACeren Erdem Altun
Ceren Erdem Altun
CCCagri Cakici
Cagri Cakici
IKIlknur Keskin
Ilknur Keskin

1 February 2017 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
HOHanefi Ozbek
Hanefi Ozbek
OAOzlem Bahadir Acikara
Ozlem Bahadir Acikara
IKIlknur Keskin
Ilknur Keskin
NKNeriman Ipek Kirmizi
Neriman Ipek Kirmizi
SOSerkan Ozbilgin
Serkan Ozbilgin
GSGulcin Saltan
Gulcin Saltan

18 January 2017 in Proteomics
Verified
Journal Article
Closed access
PDF file
TDTuran Demircan
Turan Demircan
IKIlknur Keskin
Ilknur Keskin
SDSeda Nilgün Dumlu
Seda Nilgün Dumlu
NANilüfer Aytürk
Nilüfer Aytürk
MAMahmut Erhan Avşaroğlu
Mahmut Erhan Avşaroğlu
ABAhmet Baykal
Ahmet Baykal

1 January 2022 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
MKMervenur Kalender
Mervenur Kalender
MBMuhammet Volkan Bulbul
Muhammet Volkan Bulbul
BKBircan Kolbasi
Bircan Kolbasi
IKIlknur Keskin
Ilknur Keskin
Objective: Increasing evidence shows that three dimensional cell culture models better reflect the in vivo tumor microenvironment than two dimensional cell culture models. Co-culture models are ideal cell culture models for understanding the communication between cells and the in vivo microenvironment. Changes in expression levels of E-cadherin are closely related to cancer metastasis and progression. β-catenin mediates cell adhesion of E-cadherin. Endothelial cells are stromal cell components in the tumor microenvironment. It is known that there is little or no expression of E-cadherin in endothelial cells. Methods: In our study, both two-dimensional and three dimensional mono-culture and co-culture models were created using Huvec and Ishikawa cells (endometrial cancer cell lines) to better reflect cell interactions. Spheroids were followed for three days in the three-dimensional cell culture model. E-cadherin and β-catenin expression levels of two-dimensional and three dimensional mono-culture and co-culture models were measured by immunofluorescence staining. Spheroid images were recorded using a Z-stack. Intensity measurements in both two-dimensional and three-dimensional mono-culture and co-culture models were made using the Image J software. Study groups were evaluated by one-way analysis of variance (One-Way ANOVA). Values of p <0.05 were considered statistically significant. Results: The size of the co-culture spheroids was recorded significantly larger than the mono-culture spheroids (p <0.0001). In two (p = 0.0175) and three dimensional models (p <0.0001), expression levels of E-cadherin in the mono-culture of Ishikawa cells were recorded significantly higher than in Huvec and co-culture cells. Likewise, while the expression levels of β-catenin were higher in the mono-culture of Ishikawa cells in two-dimensional models (p 0.05). Conclusion: In summary, it has been noted that the expression levels of E-cadherin are significantly reduced in co-cultures of Ishikawa cells with Huvec cells in both two and three dimensions . These results support the idea that endothelial cells may cause changes in endometrial cancer progression by suppressing E-cadherin expression in Ishikawa cells.

1 January 2017 in Neural Regeneration Research
Verified
Journal Article
Open access
PDF file
IKIlknur Keskin
Ilknur Keskin
MGM Yalcin Gunal
M Yalcin Gunal
NANilufer Ayturk
Nilufer Ayturk
UKUlkan Kilic
Ulkan Kilic
MOMehmet Ozansoy
Mehmet Ozansoy
EKErtugrul Kilic
Ertugrul Kilic
Recent evidence exists that enoxaparin can reduce brain injury because of its anticoagulant activity. To investigate the potential therapeutic effect of enoxaparin on cold-induced traumatic brain injury, at 20 minutes after modeling, male BALB/c mouse models of cold-induced traumatic brain injury were intraperitoneally administered 3 and 10 mg/kg enoxaparin or isotonic saline solution. Twenty-four hours later, enoxaparin at 10 mg/kg greatly reduced infarct volume, decreased cell apoptosis in the cortex and obviously increased serum level of total antioxidant status. By contrast, administration of enoxaparin at 3 mg/kg did not lead to these changes. These findings suggest that enoxaparin exhibits neuroprotective effect on cold-induced traumatic brain injury in a dose-dependent manner.